Educational Background

Macalester College, B.A., Biology (cum laude), 2006

University of Minnesota Medical School, M.D., 2011

Residency: Internal Medicine, University of Washington, 2011–2014

Fellowship: Pulmonary, Critical Care & Sleep Medicine, University of Washington, 2015–2018

Professional Career

Assistant Professor of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of Washington. Principal Investigator of an NIH-funded pulmonary vascular biology laboratory. Medical Director of the UW Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program and Associate Director of the UW Hereditary Hemorrhagic Telangiectasia (HHT) Center.

Research Field

In vitro modeling of pulmonary arterial hypertension using bioengineered vascular platforms

Hemodynamic forces and pulmonary endothelial dysfunction

Translational multi-omics in pulmonary arterial hypertension

Diagnosis and management of chronic thromboembolic pulmonary hypertension

Papers, Books, etc.

Author of 44 peer-reviewed publications spanning pulmonary vascular disease, vascular biology, and related fields. Selected highlights:

Rayner SG et al. Multiphoton-guided Creation of Complex Organ-specific Microvasculature. Adv Healthc Mater. 2021.

Rayner SG et al. Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement. Am J Respir Crit Care Med. 2024.

Hirsch K*, Mandrycky CJ*, Kwan I, …Rayner SG. Endothelial Responses to Shear Stress and Pressure in PAH. bioRxiv. 2025 (under review).

Educational Background

Apr 1982- Mar 1988 MD; Okayama University Medical School

May 1988- Apr 1990 National Okayama Hospital, Department of Internal Medicine, Residency

May 1990- Apr 1993 National Cardiovascular Center, Department of Cardiology, Residency

Sep 2000 PhD; Okayama University Graduate School of Medicine and Dentistry

Professional Career

Okayama University Graduate School of Medicine and Dentistry, Department of Cardiology; Associate Professor (May 2000- Apr 2003)

National Hospital Organization, Okayama Medical Center, Department of Cardiology; Director (May 2003- Mar 2020, Department of Clinical Science; Director (May 2010- Mar 2019)

Entire Medical Departments; Director (Apr 2019 - Mar 2021), Vice President (Apr 2021 – active)

Research Field

clinical and physiological aspects of pulmonary hypertension

diagnosis and treatment of Group I PH

Interventional treatment of Group IV PH

Papers, Books, etc.

J Heart Lung Transplant. 2025. doi: 10.1016/j.healun.2025.10.031

Lancet Respir Med. 2025. doi: 10.1016/S2213-2600(25)00127-4

Circ Cardiovasc Interv. 2025. doi: 10.1161/CIRCINTERVENTIONS.125.016172

J Am Coll Cardiol. 2025;85:2270-2284. doi: 10.1016/j.jacc.2025.04.021

Clin Nucl Med. 2025;50:623-630. doi: 10.1097/RLU.0000000000005919

Educational Background

Medical Graduate 2006 – 2012 Doctor of Medicine Keio University School of Medicine, Tokyo, JAPAN

Doctoral Course 2017 – 2020 Doctor of Philosophy Keio University School of Medicine, Tokyo, JAPAN

Professional Career

Residency 2012 - 2014 Internal Medicine Keio University Hospital, Tokyo, JAPAN

Fellowship 2014 - 2017 Cardiology Yokohama Citizen’s Municipal Hospital Kanagawa, JAPAN

Research Fellowship 2017 - 2020 Cardiology Keio University School of Medicine, Tokyo, JAPAN

Postdoctoral Fellowship 2021 – Present Cardiology Keio University School of Medicine, Tokyo, JAPAN

Fellowship 2025 – Present Medical genomics National Cerebral and Cardiovascular Center, Osaka, JAPAN

Research Field

I have focused on understanding the molecular mechanisms of pulmonary hypertension, right ventricular dysfunction, cardiac hypertrophy, and vascular diseases. I have conducted extensive basic researches on developing new therapies for the treatment of pulmonary arterial hypertension (PAH) using gene-editing technologies. My current role as a clinical physician at Keio University Hospital allows me to combine clinical practice with my research endeavors.
My researches have been recognized with several awards, including the “Best Young Investigator’s Award” and “Outstanding Research Award” from the Japan Cardiovascular Society, the “Young Researcher Award” from the European Society of Cardiology Pulmonary Circulation and Right Ventricular Function Working Group, the “Moderated Poster Presentation Winner” from the European Society of Cardiology, the “Oral Presentation Award” at the 1st Asian Cardiovascular Symposium at Basic Cardiovascular Sciences held in the USA, and the “Best Young Investigator’s Award” at the Japanese Pulmonary Circulation and Pulmonary Hypertension Society Conference.

Papers, Books, etc.

Hiraide T, Tsuda N, Momoi M, et al. CXCL12/CXCR4 pathway as a novel therapeutic target for RNF213-associated pulmonary arterial hypertension. Sci Rep. 2024;14:26604.

Hiraide T, Suzuki H, Momoi M, et al. RNF213-associated vascular disease: a concept unifying various vasculopathies. Life. 2022;12:555.

Hiraide T, Kataoka M, Suzuki H, et al. Poor outcomes in carriers of the RNF213 variant (p.Arg4810Lys) with pulmonary arterial hypertension. J Heart Lung Transplant. 2020;39:103–112.

Hiraide T, Kataoka M, Suzuki H, Aimi Y, Chiba T, Kanekura K, Satoh T, Fukuda K, Gamou S, Kosaki K. SOX17 mutations in Japanese patients with pulmonary arterial hypertension. Am J Respir Crit Care Med. 2018;198:1231–1233.

Hiraide T, Teratani T, Uemura S, et al. Pulmonary arterial hypertension caused by AhR signal activation protecting against colitis. Am J Respir Crit Care Med. 2021;203:385–388.

Educational Background

B.S. in Medicine, Ulsan University, Ulsan, Republic of Korea

M.D. in Medicine, Ulsan University, Ulsan, Republic of Korea

Ph,D in Medicine, Ulsan University, Ulsan, Republic of Korea

Professional Career

Internship, Asan Medical Center

Residency, Department of Internal Medicine, Asan Medical Center

Clinical fellowship, Department of Pulmonology and Critical Care Medicine, Asan Medical Center

Assistant Professor, Department of Pulmonology and Critical Care Medicine, Asan Medical Center

Research Field

Pulmonary hypertension

Venous thromboembolism

Airway disease

Educational Background

1993년 3월 ~ 1999년 2월 고려대학교 의과대학 의학사

2002년 3월 ~ 2004년 2월 고려대학교 의과대학 대학원 의학 석사 (내과학)

2004년 3월 ~ 2007년 2월 고려대학교 의과대학 대학원 의학 박사 (순환기내과)

Professional Career

1999년 3월 ~ 2000년 2월 고려대학교 병원 수련의

2000년 3월 ~ 2004년 2월 고려대학교 병원 내과 전공의

2004년 3월 ~ 2007년 2월 고려대학교 병원 순환기 내과 전임의/임상강사

2007년 5월 ~ 2009년 4월 Brigham and Women’s Hospital Research Fellow

2009년 5월 ~ 2010년 2월 인하대학교 병원 심장내과 임상강사

2010년 3월 ~ 2014년 2월 인하대학교 병원 심장내과 조교수

2014년 3월 ~ 2019년 2월 인하대학교 병원 심장내과 부교수

2018년 ~ 2019년 Brigham and Women’s Hospital Visiting Associate Professor

2019년 3월 ~ 현재 인하대학교 병원 심장내과 교수

학회

대한내과학회 현) 윤리위원

대한심장학회 현) 편집위원, 정책위원

한국심초음파학회 현) 홍보이사

대한심부전학회 현) 국제교류이사

대한고혈압학회 현) 홍보위원

Educational Background

Prof. Jing obtained his M.D. Ph.D. degree in 1998 from Peking Union Medical College, and then participated in 2-year postdoctoral clinical fellow training at the Hospital Antoine Béclère with Professors Gerald Simonneau and Marc Humbert, in Paris-Sud Université, France. He also received the training by World Heart Federation Emerging Leaders Programme and the American College of Cardiology Global Leadership Training program in 2014.

Professional Career

Prof. Jing is the Chairman of the Cardiovascular Medicine Department, Guangdong Cardiovascular Institute. He also is the associate Editor of HEART (the BMJ family journals), Senior Editor of JACC, the President of Guangdong Society of Cardiology. Prof. Jing led more than 100s International and National project / clinical trials on the genetics and basic / clinic research on pulmonary circulation and thrombosis, he is also the lead author on the National Clinical Guideline for Pulmonary Embolism and Pulmonary Hypertension organized by Chinese Society of Cardiology. He received almost all of most important National awards for Scientist-Physicians.

Research Field

Cardiovascular Medicine

Congenital heart disease

Pulmonary Circulation

Papers, Books, etc. presented or published under your name

Clinical features and survival in Taksyasu's arteritis-associated pulmonary hypertension: a nationwide study. Eur Heart J. 2021;42(42):4298-4305.

Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension. J Am Coll Cardiol. 2022;79(15):1477-1488.

Prognostic Value of Plasma Immunoglobulin G N-Glycome Traits in Pulmonary Arterial Hypertension. J Am Coll Cardiol. 2024; 84(12):1092-1103.

Evaluation of recombinant human prourokinase for acute pulmonary embolism: A phase 2, randomized clinical trial. Med. 2026 Mar 30:101068.

sST2 and IL-6 predict prognosis of medically treated chronic thromboembolic pulmonary hypertension. Eur Respir J. 2026 Jan 22:2502367.

Educational Background

Professor Aldalaan earned his medical degree from King Saud University. He completed residencies in internal medicine at King Faisal Specialist Hospital & Research Centre and Duke University Medical Center. He then completed a pulmonary and critical care fellowship at the University of Virginia.

Professional Career

Abdullah Moshin Aldalaan, MBBS, is Director of the Pulmonary Hypertension Program of Excellence and a Consultant Pulmonologist at the King Faisal Specialist Hospital & Research Centre in Riyadh, Saudi Arabia. He also serves as a Professor in the College of Medicine at Alfaisal University, also located in Riyadh. In addition to his current role as President of the Saudi Association for Pulmonary Hypertension, Dr. Aldalaan has held leadership positions in numerous professional societies focused on respiratory disease and has lectured nationally and internationally.

Research Field

Dr. Aldalaan established the lung transplant program at King Faisal Specialist Hospital & Research Centre in 2003. He also established the institution’s pulmonary hypertension (PH) treatment program, which is the only program in the area providing comprehensive diagnostic and therapeutic protocols for patients with PH. The program offers all available internationally recognized medical interventions for PH and has become a region-wide reference center for pulmonary hypertension education and treatment.

Papers, Books, etc. presented or published by your name

Dr. Aldalaan also is an active clinical trialist and has published more than 50 papers in peer-reviewed journals.

Recent publication of note:
Aldalaan A, Saleemi SA, Weheba I, et al. Prospective clinical assessment of patients with pulmonary arterial hypertension switched from bosentan to macitentan (POTENT). Pulm Circ. 2022;12:e12083, doi: 10.1002/pul2.12083.

Educational Background

Apr 1982- Mar 1988 MD; Okayama University Medical School

May 1988- Apr 1990 National Okayama Hospital, Department of Internal Medicine, Residency

May 1990- Apr 1993 National Cardiovascular Center, Department of Cardiology, Residency

Sep 2000 PhD; Okayama University Graduate School of Medicine and Dentistry

Professional Career

Okayama University Graduate School of Medicine and Dentistry, Department of Cardiology; Associate Professor (May 2000- Apr 2003)

National Hospital Organization, Okayama Medical Center, Department of Cardiology; Director (May 2003- Mar 2020, Department of Clinical Science; Director (May 2010- Mar 2019), Entire Medical Departments; Director (Apr 2019 - Mar 2021), Vice President (Apr 2021 – active)

Research Field

clinical and physiological aspects of pulmonary hypertension

diagnosis and treatment of Group I PH

Interventional treatment of Group IV PH

Papers, Books, etc. presented or published by your name

JACC Cardiovasc Interv. 2024;17:707-708. doi: 10.1016/j.jcin.2023.11.022

Eur Respir J. 2024. doi: 10.1183/13993003.01294-2024

Can J Cardiol. 2024. doi: 10.1016/j.cjca.2024.05.003

J Heart Lung Transplant. 2024. doi: 10.1016/j.healun.2024.05.007

Circulation. 2024. doi: 10.1161/CIRCULATIONAHA.124.068610

Educational Background

Visiting Scholar , University of Chicago Medical Center

PhD, Institute of Clinical Medicine, National Cheng Kung University, Tainan, Taiwan

Master Degree, Pulmonary Vascular Disease, University of Bologna, Bologna, Italy

MD, China Medical College, Taichung, Taiwan

Professional Career

2022- Professor, National Cheng Kung University

2023-, Deputy Superintendent, National Cheng Kung University Hospital

2020-2023 Medical Secretory, National Cheng Kung University Hospital

2019-2020 Deputy Superintendent, National Cheng Kung University Hospital Dou-Liou Branch

2004 Attending Physician, National Cheng Kung University Hospital

Research Field

Pulmonary Hypertension

Heart Failure

Heart Transplant Care

Critical Care

Post Resuscitation Care

Educational Background

1991.3 Graduate from Kyushu University School of Medicine

1993.6-1995.5 Research Fellow, Cardiovascular Medicine, Kyushu University

1998.10-2001.11 Research Fellow, Brigham and Women’s Hospital, Harvard Medical School

2011.8-2013.6 Associate Professor, Cardiovascular Medicine, Tohoku University

2013.7-Present Professor and Chairman, Cardiovascular Medicine, Kurume University

Professional Career

Yoshihiro Fukumoto is Professor and Chairman of Cardiovascular Medicine in Kurume University School of Medicine, who is also a Fellow of JCC, JCS, AHA, and ESC. Dr. Fukumoto was awarded his medical degree from Kyushu University School of Medicine, and followed this with a PhD in coronary arteriosclerosis in Kyushu University, Fukuoka, Japan. He is a president of Japanese Pulmonary Circulation and Pulmonary Hypertension Society (since April 2024), Japanese Association of Cardiac Rehabilitation (since August 2024).

Research Field

General cardiology

Pulmonary circulation

Heart failure

atherosclerosis

Cardiac rehabilitation

Papers, Books, etc. presented or published by your name

Minatsuki S, Fukumoto Y, et al. Significance of diffusing capacity of the lungs for carbon monoxide on chronic thromboembolic pulmonary hypertension. Thorax. 2026:thorax-2025-223670.

Sugiyama Y, Fukumoto Y, et al. Utility of liver stiffness for the classification of portopulmonary hypertension in precapillary pulmonary hypertension. Int J Cardiol. 2025;429:133126.

Satoh T, Fukumoto Y, et al. Hypopituitarism Induced by Continuous Infusion of PGI2 Analogues: A Case Series and the Role of ACTH Screening and Hydrocortisone Treatment. Pulm Circ. 2025;15:e70116.

Yamashita J, Fukumoto Y, et al. Effects of pulmonary endarterectomy and balloon pulmonary angioplasty in older adults with chronic thromboembolic pulmonary hypertension: A sub-analysis of the CTEPH AC registry. Int J Cardiol Heart Vasc. 2025;60:101751.

Yamaji K, Fukumoto Y, et al. Catheter-based examination for pulmonary microcirculatory function in patients with pulmonary hypertension. PLoS One. 2024;19:e0312609.

Educational Background

Prof. Dr. med. Stephan Rosenkranz completed his Doctoral dissertation at Justus-Liebig-Universität Gießen, Gießen, Germany; a Post-doctoral fellowship at Harvard Medical School, Boston, Massachusetts, USA; and a residency and research fellowship at the Klinik III für Innere Medizin (Dept. of Cardiology), University of Cologne, Germany.

Professional Career

Prof. Dr. med. Stephan Rosenkranz currently holds the posts of Chair, Cologne Cardiovascular Research Center (CCRC); Full Professor of Cardiology (“Cardiopulmonary interaction”), University of Cologne; Head of Expert Center on Pulmonary Hypertension; Associate editor of European Journal of Heart Failure, Cardiovascular Research, Current Heart Failure Reports; and as a reviewer for numerous scientific journals, including Journal of the American Medical Association, Lancet, European Heart Journal.

Research Field

Prof. Dr. med. Stephan Rosenkranz has experience in numerous clinical trials in the field of heart failure and pulmonary hypertension (phase I, II, III, IV) and is Head ("Principal Investigator") of the working group on "Molecular Cardiology," with a research focus of Signal transduction and pathobiological relevance of tyrosine kinases in cardiovascular disease.

Papers, Books, etc. presented or published by your name

Most recently: Rosenkranz S, Ghofrani HA, Hoeper MM, et al. Safety and efficacy of riociguat in patients with pulmonary arterial hypertension and cardiometabolic comorbidities:
Data from interventional clinical trials [published correction appears in J Heart Lung Transplant.
2025:S1053-2498(25)01764-4. doi: 10.1016/j.healun.2025.02.1679.]. J Heart Lung Transplant. 2025;44(2):135-146. doi:10.1016/j.healun.2024.08.018

Educational Background

College: Harvard University, 1989, A.B. (Magna Cum Laude, Biology)

Medical School: University of Chicago Pritzker School of Medicine, 1994, M.D.

Internship: University of Chicago, Internal Medicine, 1994-1995, 1996-1998

Residency: University of California San Francisco, Anesthesiology, 1995-1996

Fellowship: University of California San Diego, Pulmonary and Critical Care Medicine, 1998-2001

Professional Career

Faculty at UCSD since 2001. Fellowship program director 2009-2017. Currently, Professor of Medicine in the Division of Pulmonary, Critical Care, Sleep Medicine, & Physiology. Section Chief of Pulmonary Vascular Medicine. Medical Director of Pulmonary Thromboendarterectomy Program.

Research Field

Evaluation and treatment of pulmonary arterial hypertension

Interventional and medical management of chronic thromboembolic disease

Perioperative management following pulmonary thromboendarterectomy

Balloon pulmonary angioplasty for chronic thromboembolic disease

Clinical trials in pulmonary hypertension

Papers, Books, etc. presented or published by your name

As of Nov 2025: 132 peer-reviewed publications on pulmonary hypertension including, pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

Lead author for the 5th, 6th, and 7th World Symposium on Pulmonary Hypertension task force on “Chronic Thromboembolic Pulmonary Hypertension”. 4th World Symposium on Pulmonary Hypertension task force member: “Endpoints and Clinical Trial Design in PAH” and “Interventional and Surgical Modalities of Treatment in PH”.

Educational Background

1998-2004 Pusan National University, College of Medicine, Medicine, Bachelor

2005~2007 Pusan National University, College of Medicine, Internal medicine, MMed

2012~2013 Pusan National University, College of Medicine, Internal medicine, Ph.D.

Professional Career

Feb 2004 Korean Medical License (No. 82164)

Mar 2009 Korean Board of Internal Medicine (No. 11607)

Oct 2015 Korean Subspecialty Board of Cardiology (No. 2-15-1019)

Mar 2021~ present: Assistant Professor, Internal Medicine (Division of Cardiology), Pusan National University Yangsan Hospital, Yangsan, Korea

Research Field

Echocardiography,

Pulmonary Hypertension,

Hypertension / Dyslipidemia,

Cardiac amyloidosis / Cardiac Sarcoidosis

Papers, Books, etc. presented or published by your name

Value of Coronary Angiography in the Cardiac Myxoma. Clin Anat. 2019 Nov 21. doi: 10.1002/ca.23527

Mitral Loop Cerclage Annuloplasty for Secondary Mitral Regurgitation: First Human Results. JACC Cardiovasc Interv. 2017 Mar 27;10(6):597-610

Prognostic Significance of Presenting Blood Pressure in Patients with ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Am J Hypertens. 2015 Jun;28(6):797-805.

Right Cardiac Catheterization Using the Antecubital Fossa Vein in Korean Patients. Korean Circ J. 2016 Mar;46(2):207-12.

Educational Background

1992.3-1998.2: Seoul National University, College of Medicine. Received the certificate of medical doctor

2002.3-2007.2: Graduate School of Seoul National University, College of Medicine Received the degree of Master in Pediatrics

2007.3-2010.2 Graduate School of Seoul National University, College of Medicine Received the degree of Ph.D.in Pediatrics

Professional Career

2021.3- present: Professor Department of Pediatrics, Seoul National University Children’s Hospital Seoul National University, College of Medicine

2013.10- 2021.2: Associate Professor, Department of Pediatrics, Seoul National University Children’s Hospital

2013.3-2014.2: Research Fellowship Division of Interventional Cardiology, Department of Pediatrics, Boston Children’s Hospital, USA

2008.3- 2013.9: Assistant Professor, Department of Pediatrics, Seoul National University Children’s Hospital

Research Field

Pediatric cardiac intervention

Pulmonary hypertension

Cardiomyopathy and heart transplantation

Kawasaki disease

Adult congenital heart disease

Papers, Books, etc. presented or published by your name

1. Park WY, Kim GB, Lee SY, Kim AY, Choi JY, Jang SI, Kim SH, Cha SG, Wang JK, Lin MT, Chen CA. The adaptability of the Pulsta valve to the diverse main pulmonary artery shape of native right ventricular outflow tract disease. Catheter Cardiovasc Interv. 2024 Feb 11.

2. Lee SY, Kim GB, Kim SH, Jang SI, Choi JY, Kang IS, Kim YH. Mid-term outcomes of the Pulsta transcatheter pulmonary valve for the native right ventricular outflow tract. Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29865

3. Kim GB, Song MK, Bae EJ, Park EA, Lee W, Lim HG, Kim YJ. Successful Feasibility Human Trial of a New Self-Expandable Percutaneous Pulmonary Valve (Pulsta Valve) Implantation Using Knitted Nitinol Wire Backbone and Trileaflet α-Gal-Free Porcine Pericardial Valve in the Native Right Ventricular Outflow Tract. Circ Cardiovasc Interv. 2018 Jun;11(6):e006494

Educational Background

Feb ’10 Graduate from Chung-Ang University, College of Medicine

Feb ’19 Master of Pediatrics from Seoul National University, College of Medicine

Feb ’21 Ph.D course from Seoul National University, College of Medicine

Professional Career

Mar ‘10~ Feb ’11 : Internship at Seoul National University Hospital

Mar ‘11~ Feb ’15 : Residency in Department of Pediatrics at Seoul National University Hospital

Mar ‘15~ Feb ’17 : Clinical Fellow of Department of Pediatric Cardiology at Seoul National University Hospital

Mar ‘17~ : Clinical Assistant Professor, Department of Pediatric Cardiology at Gachon University Gil Medical center

Mar ‘23~ : Assistant Professor, Department of Pediatric Cardiology at Gachon University Gil Medical center

Research Field

Pediatric congenital heart disease

Adult congenital heart disease

Heart failure

Pulmonary hypertension

Kawasaki disease

Arrhythmia

Papers, Books, etc. presented or published by your name

Ahn KJ, Song MK, Lee SY, Yoon JK, Kim GB, Oh S, et al. The outcome of Long QT syndrome, a Korean single center study. Korean Circulation Journal. 2022;52(10):771-81.

Yeo J, Shin N, Ahn K-J, Seo M, Jang AY, Kim M, et al. Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension. Clinical Hypertension. 2022;28(1):1-4.

Oh S, Jung J-H, Ahn K-J, Jang AY, Byun K, Yang PC, et al. Stem Cell and Exosome Therapy in Pulmonary Hypertension. Korean Circulation Journal. 2022;52(2):110-22.

Ahn KJ, Yu J, Jang AY, Kim D-H, Kwan J, Chung W-J. Valsartan Dosage on Ventriculo-Vascular Coupling Index Dose-Dependency in Heart Failure Patients. Yonsei Medical Journal. 2021;62(5):391.

Ahn KJ, Song MK, Kim GB, Kim WH, Bae EJ. Successful catheter ablation for ventricular tachycardia after cone procedure in Ebstein anomaly. HeartRhythm Case Rep. 2019 Nov 18;6(2):106-109.

Ahn KJ, Jang AY, Park SJ, Chung W-J. 15 years journey of idiopathic pulmonary arterial hypertension with BMPR2 mutation. Clinical Hypertension. 2019;25(1):1-4

Educational Background

Undergraduate/college: Davidson College, 2007-2011 – Bachelor of Science (BS)

Medical school: Jefferson Medical College at Thomas Jefferson University, 2011-2015 – Medical Degree (MD)

Internship/Residency: University of California San Diego, 2015-2018 – Internal Medicine

Fellowship: University of California San Diego, 2018-2021 – Pulmonary and Critical Care Medicine

Professional Career

Assistant Clinical Professor of Medicine, Pulmonary and Critical Care Medicine: University of California San Diego, 2021-2025

Staff Physician, Pulmonary and Critical Care Medicine: Veterans Affairs San Diego Medical Center, 2021-2023

Associate Clinical Professor of Medicine, Pulmonary and Critical Care Medicine: University of California San Diego, 2025-present

Research Field

Chronic thromboembolic pulmonary hypertension (CTEPH)

Pulmonary arterial hypertension (PAH)

Exercise pulmonary hypertension/ invasive cardiopulmonary exercise test

Papers, Books, etc. presented or published by your name

Yang JZ, Poch DS, Ang L, Mahmud E, Bautista MA, Alotaibi M, Fernandes TM, Kerr KM, Papamatheakis DG, Kim NH. “Tricuspid annular plane systolic excursion to pulmonary artery systolic pressur ratio in chronic thromboembolic pulmonary hypertension improves with balloon pulmonary angioplasty.” Pulmonary Circulation. October 2024;14(4):e12452.

Yang JZ, Kim NH, Kligerman S, Fernandes TM, Papamatheakis DG, Poch DS, Alotaibi M, Pretorius VG, Madani MM, Kerr KM. “Outcomes Associated with Catheter-Directed Therapies in Chronic Thromboembolic Pulmonary Hypertension: Cautionary Tales from a Single-center Case Series.” CHEST Pulmonary. September 2023; 1(2):100009. https://doi.org/10.1016/j.chpulm.2023.100009.

Yang J, Madani MM, Mahmud E, Kim NH. “Evaluation and Management of Chronic Thromboembolic Pulmonary Hypertension.” CHEST. August 2023; 164 (2): 490-502.

Yang JZ, Odish MF, Mather H, Pebley N, Wardi G, Kim NH, Papamatheakis DG, Poch DS, Fernandes TM, Sell RE. “Outcomes of Cardiopulmonary Resuscitation in Pulmonary Arterial Hypertension.” Pulmonary Circulation. April 2022. 12(2):e12066.

Yang JZ, Fernandes TM, Kim NH, Kerr K, Poch DS, Lombardi S, Melber D, Kelly T, Papamatheakis D. “Pregnancy and pulmonary arterial hypertension: A case series with long term follow up and literature review.” American Journal of Obstetrics & Gynecology: Maternal-Fetal Medicine. July 2021. 3(4):100358.

Educational Background

Nanjing Medical University (China)

Professional Career

Doctor of Medicine, Chief physician, Professor, doctoral supervisor

Vice Chairman of the Heart Failure Committee of China Research Hospital

Youth member, Heart Rhythm Branch, Chinese Medical Doctor Association

Deputy Chairman of the heart failure Committee of Jiangsu Medical Association

Deputy head of pacing Group, Electrophysiology and Pacing Branch Jiangsu Medical Association

Research Field

Diagnosis and treatment of arrhythmia, heart failure and pulmonary hypertension.

Pacemaker, CRT, ICD implantation, RHC, and related application of basic research.

Papers, Books, etc. presented or published by your name

Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial. JACC Cardiovasc Interv. 2022 Dec 12;15(23):2412-2423. doi: 10.1016/j.jcin.2022.09.013. Epub 2022 Sep 18.

3Year Outcome in Patients With Combined Precapillary and Postcapillary Pulmonary Hypertension: Results From PADN-5 Trial. JACC Heart Fail 2023 Aug;11(8 Pt 2):1135-1146. doi: 10.1016/j.jchf.2023.05.016. Epub 2023 Jun 21.

Pulmonary Artery Denervation: Update on Clinical Studies. Curr Cardiol Rep. 2019 Sep 5;21(10):124. doi: 10.1007/s11886-019-1203-z.

Educational Background

1976 – 1978 Premedical Course, Tokyo Medical and Dental University, Chiba, Japan

1978 – 1982 M.D., Tokyo Medical and Dental University, Tokyo, Japan

2000 Ph.D. (Doctor of Medicine), Tokyo Medical and Dental University, Tokyo, Japan

Professional Career

1991 Board certified in Pediatrics, Japanese Pediatric Society

2011 Board certified in Pediatric Cardiologist, Japanese Society of Pediatric Cardiology and Cardiac Surgery

2011 Board certified in PALS provider, American Heart Association

Research Field

Japanese Medical Specialty Board and Instructor of Pediatrics

Specialty Board of Pediatric Cardiology

Honorary fellow of Japanese Society of Pediatric Cardiology and Cardiac Surgery

Honorary fellow of Japanese Pulmonary Circulation and Pulmonary Hypertension Society

Papers, Books, etc. presented or published by your name

Implantable Cardioverter Defibrillator for Primary Prevention in Children With Arrhythmogenic Right Ventricular Cardiomyopathy: A Case Series. Cureus. 2025 Jan 10;17(1):e77253

Systematic Review of the Application of Pulmonary Hypertension Treatments in Ventricular Septal Defect, Pulmonary Atresia, and Major Aortopulmonary Collateral Arteries. J Clin Med. 2026 Jan 30;15(3):1087. doi: 10.3390/jcm15031087